1-5 of 5
Stanley C. Gill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Post-Hoc Analysis of Measurable Residual Disease from BMT-CTN 1506/Morpho: FLT3-ITD Variant Allele Frequency and Survival Are Highly Correlated

Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Richard J. Jones, Anurag K. Singh, Mark R. Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander Perl, Robert J. Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L Uy, Edmund K. Waller, Sumithira Vasu, Melhem M. Solh, Asmita Mishra, Lori S. Muffly, Hee-Je Kim, Matthias Stelljes, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H. Wei, Guido Marcucci, Nahla Hasabou, Mathew Rosales, Jason Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabel, Steven M. Devine, Mary M. Horowitz, Yi-Bin Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 973.
https://doi.org/10.1182/blood-2023-177929
Published: 2023
Journal Articles

Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3 mut+ AML ineligible for intensive chemotherapy

Clinical Trials & Observations
Eunice S. Wang, Pau Montesinos, Mark D. Minden, Je-Hwan Lee, Michael Heuser, Tomoki Naoe, Wen-Chien Chou, Kamel Laribi, Jordi Esteve, Jessica K. Altman, Violaine Havelange, Anne-Marie Watson, Carlo Gambacorti-Passerini, Elzbieta Patkowska, Shufang Liu, Ruishan Wu, Nisha Philipose, Jason E. Hill, Stanley C. Gill, Elizabeth Shima Rich, Ramon V. Tiu
Journal: Blood
Blood (2022) 140 (17): 1845–1857.
https://doi.org/10.1182/blood.2021014586
Published: 2022
Includes: Supplemental data
Journal Articles

Final Results of the Chrysalis Trial: A First-in-Human Phase 1/2 Dose-Escalation, Dose-Expansion Study of Gilteritinib (ASP2215) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Alexander E. Perl, MD, Jessica K. Altman, MD, Jorge E. Cortes, MD, Catherine C. Smith, MD, Mark Litzow, MD, Maria R. Baer, MD, David F. Claxton, MD, Harry P. Erba, MD PhD, Stanley C. Gill, PhD, Stuart L. Goldberg, MD, Joseph G. Jurcic, MD, Richard A. Larson, MD, Charles Liu, PhD, Ellen K. Ritchie, MD, Gary J. Schiller, MD, Alexander I. Spira, MD PhD, Stephen A. Strickland, Raoul Tibes, MD PhD, Celalettin Ustun, MD, Eunice S. Wang, MD, Robert K. Stuart, MD, Christoph Röllig, MD, Andreas Neubauer, Giovanni Martinelli, Erkut Bahceci, MD, Mark J. Levis, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1069.
https://doi.org/10.1182/blood.V128.22.1069.1069
Published: 2016
Journal Articles

Antileukemic Activity and Tolerability of ASP2215 80mg and Greater in FLT3 Mutation-Positive Subjects with Relapsed or Refractory Acute Myeloid Leukemia: Results from a Phase 1/2, Open-Label, Dose-Escalation/Dose-Response Study

Jessica K. Altman, MD, Alexander E. Perl, MD, Jorge E. Cortes, MD, Mark J. Levis, MD PhD, Catherine C. Smith, MD, Mark R Litzow, MD, Maria R. Baer, David F. Claxton, MD, Harry P. Erba, MD PhD, Stanley C. Gill, PhD, Stuart L. Goldberg, Joseph G. Jurcic, MD, Richard A. Larson, MD, Charles Lui, PhD, Ellen K Ritchie, MD, Briana Sargent, BS, Gary J Schiller, MD, Alexander I. Spira, MD PhD, Stephen A. Strickland, MD, Raoul Tibes, MD PhD, Celalettin Ustun, MD, Eunice S. Wang, MD, Robert K. Stuart, MD, Claudia D. Baldus, MD PhD, Christoph Rollig, Andreas Neubauer, MD, Giovanni Martinelli, Erkut Bahceci, MD
Journal: Blood
Blood (2015) 126 (23): 321.
https://doi.org/10.1182/blood.V126.23.321.321
Published: 2015
Journal Articles

Pharmacokinetic Profile and Pharmacodynamic Effects of ASP2215, a Selective, Potent Inhibitor of FLT3/AXL, in Patients with Relapsed or Refractory Acute Myeloid Leukemia: Results from a First-in-Human Phase 1/2 Study

Catherine C. Smith, MD, Mark J. Levis, MD PhD, Mark R Litzow, MD, Alexander E. Perl, MD, Jessica K. Altman, MD, Stanley C. Gill, PhD, Takeshi Kadokura, PhD, Geoffrey J. Yuen, Pharm.D., Ogert Fisniku, MS, Charles Liu, PhD, Itsuro Nagase, PhDDVM, Briana Sargent, BS, Noreen Welter, RN, BSN, Erkut Bahceci, MD
Journal: Blood
Blood (2015) 126 (23): 4836.
https://doi.org/10.1182/blood.V126.23.4836.4836
Published: 2015